These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
177 related items for PubMed ID: 14688807
41. [Association of polymorphisms in the angiotensin system genes with obstructive sleep apnea-hypopnea syndrome]. Zhang LQ, Yao WZ, He QY, Wang YZ, Ren B, Lin YP. Zhonghua Jie He He Hu Xi Za Zhi; 2004 Aug; 27(8):507-10. PubMed ID: 15387996 [Abstract] [Full Text] [Related]
43. Reverse white-coat effect as an independent risk for microalbuminuria in treated hypertensive patients. Kato T, Horio T, Tomiyama M, Kamide K, Nakamura S, Yoshihara F, Nakata H, Nakahama H, Kawano Y. Nephrol Dial Transplant; 2007 Mar; 22(3):911-6. PubMed ID: 17142262 [Abstract] [Full Text] [Related]
44. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL). Tytus RH, Burgess ED, Assouline L, Vanjaka A. Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822 [Abstract] [Full Text] [Related]
45. Beta2-adrenergic receptor polymorphisms and treatment-induced regression of left ventricular hypertrophy in hypertension. Iaccarino G, Izzo R, Trimarco V, Cipolletta E, Lanni F, Sorriento D, Iovino GL, Rozza F, De Luca N, Priante O, Di Renzo G, Trimarco B. Clin Pharmacol Ther; 2006 Dec; 80(6):633-45. PubMed ID: 17178264 [Abstract] [Full Text] [Related]
47. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study. Mallion JM, Chamontin B, Asmar R, De Leeuw PW, O'Brien E, Duprez D, O'Rourke MF, Rahn KH, Romero R, Battegay E, Hitzenberger G, Safar ME, REASON Project. Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199 [Abstract] [Full Text] [Related]
48. [Association of angiotensinogen gene polymorphism with hypertension in type 2 diabetic patients]. Xue YM, Guan MP, Liu SQ, Zhang Q, Zhou L. Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1191-3. PubMed ID: 14625185 [Abstract] [Full Text] [Related]
49. Effect of antihypertensive treatment on qualitative estimates of microalbuminuria. Agrawal B, Wolf K, Berger A, Luft FC. J Hum Hypertens; 1996 Aug; 10(8):551-5. PubMed ID: 8895040 [Abstract] [Full Text] [Related]
51. Microalbuminuria as a marker of cardiac damage in essential hypertension. Mettimano M, Specchia ML, Migneco A, Savi L. Eur Rev Med Pharmacol Sci; 2001 Aug; 5(1):31-6. PubMed ID: 11860221 [Abstract] [Full Text] [Related]
52. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2. Ekbom T, Linjer E, Hedner T, Lanke J, De Faire U, Wester PO, Dahlöf B, Scherstén B. Blood Press; 2004 Aug; 13(3):137-41. PubMed ID: 15223721 [Abstract] [Full Text] [Related]
53. [Pharmacogenetics of angiotensin system in non diabetic nephropathy]. Coto E, Marín R, Alvarez V, Praga M, Fernández Andrade C, Arias M, Poveda R, Vallés M, Galcerán JM, Luño J, Rivera F, Campistol JM. Nefrologia; 2005 Aug; 25(4):381-6. PubMed ID: 16231503 [Abstract] [Full Text] [Related]
54. Angiotensinogen genotype predicts abnormal renal hemodynamics in young hypertensive patients. Patel TV, Williams GH, Fisher ND. J Hypertens; 2008 Jul; 26(7):1353-9. PubMed ID: 18551010 [Abstract] [Full Text] [Related]
55. [Effect of ACE gene polymorphism on carbohydrate metabolism, on oxidative stress and on end-organ damage in type-2 diabetes mellitus]. Molnár GA, Wagner Z, Wagner L, Melegh B, Kószegi T, Degrell P, Bene J, Tamaskó M, Laczy B, Nagy J, Wittmann I. Orv Hetil; 2004 Apr 18; 145(16):855-9. PubMed ID: 15156690 [Abstract] [Full Text] [Related]
56. [The relationship between haplotypes of angiotensinogen gene and essential hypertension]. Kong X, Zhang S, Yang Y, Zheng K, Tong Y, Shi J, Zhang K, Su Z, Cheng W. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Dec 18; 19(6):488-90. PubMed ID: 12476421 [Abstract] [Full Text] [Related]
57. Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol. Johnson JA, Zineh I, Puckett BJ, McGorray SP, Yarandi HN, Pauly DF. Clin Pharmacol Ther; 2003 Jul 18; 74(1):44-52. PubMed ID: 12844134 [Abstract] [Full Text] [Related]
58. Renin-angiotensin system gene polymorphisms: relationship with blood pressure and microalbuminuria in telmisartan-treated hypertensive patients. Redon J, Luque-Otero M, Martell N, Chaves FJ, POLPRI Investigators. Pharmacogenomics J; 2005 Jul 18; 5(1):14-20. PubMed ID: 15505642 [Abstract] [Full Text] [Related]
60. The gain-of-function G389R variant of the beta1-adrenoceptor does not influence blood pressure or heart rate response to beta-blockade in hypertensive subjects. O'Shaughnessy KM, Fu B, Dickerson C, Thurston D, Brown MJ. Clin Sci (Lond); 2000 Sep 18; 99(3):233-8. PubMed ID: 11787477 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]